Regional phospholipase A2 activity in apolipoprotein E genotyped Alzheimer disease brains

被引：0
|
作者：
Yarger, DE
Ramassamy, C
Krzywkowski, P
Poirier, J
Rapoport, SI
Murphy, EJ
机构：
[1] Cumberland Coll, Dept Biol, Williamsburg, KY 40769 USA
[2] Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada
[3] NIA, Neurosci Lab, Bethesda, MD 20892 USA
来源：
JOURNAL OF NEUROCHEMISTRY | 1999年 / 72卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [21] Apolipoprotein E and Alzheimer disease
    Huang, YD
    NEUROLOGY, 2006, 66 : S79 - S85
  • [22] Apolipoprotein E and Alzheimer disease
    Growdon, JH
    ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1053 - 1054
  • [23] Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
    Chalbot, Sonia
    Zetterberg, Henrik
    Blennow, Kaj
    Fladby, Tormod
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    CLINICAL CHEMISTRY, 2009, 55 (12) : 2171 - 2179
  • [24] Apolipoprotein E and Alzheimer disease
    Roses, AD
    Saunders, AM
    Corder, EH
    Risch, NJ
    Haines, JL
    PericakVance, MA
    Han, SH
    Einstein, G
    Hulette, C
    Schmechel, DE
    Goedert, M
    Jakes, R
    Dong, LM
    Weisgraber, KH
    Holsti, M
    Huang, D
    Strittmatter, WJ
    PRECLINICAL AND CLINICAL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE, CEREBROVASCULAR AND MENTAL DISORDERS, 1996, 11 : 187 - 197
  • [25] Platelet phospholipase A2 activity in patients with Alzheimer’s disease, vascular dementia and ischemic stroke
    E. Krzystanek
    M. Krzystanek
    G. Opala
    H. I. Trzeciak
    J. Siuda
    A. Małecki
    Journal of Neural Transmission, 2007, 114 : 1033 - 1039
  • [26] Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke
    Krzystanek, E.
    Krzystanek, M.
    Opala, G.
    Trzeciak, H. I.
    Siuda, J.
    Malecki, A.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) : 1033 - 1039
  • [27] Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease affected brains: a possible role for apolipoprotein E in Alzheimer's disease
    Aizawa, Y
    Fukatsu, R
    Takamaru, Y
    Tsuzuki, K
    Chiba, H
    Kobayashi, K
    Fujii, N
    Takahata, N
    BRAIN RESEARCH, 1997, 768 (1-2) : 208 - 214
  • [28] Pharmacological inhibition of cytosolic phospholipase A2α decreases atherosclerosis in Apolipoprotein E deficient mice
    Clerin, V
    Resmini, C
    Hebert, G
    McKew, J
    Smith, TM
    Schaub, RG
    Clark, JD
    Xu, X
    Mollova, N
    Keith, JC
    CIRCULATION, 2005, 112 (17) : U163 - U163
  • [29] Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer's disease
    Hashimoto, M
    Yasuda, M
    Tanimukai, S
    Matsui, M
    Hirono, N
    Kazui, H
    Mori, E
    NEUROLOGY, 2001, 57 (08) : 1461 - 1466
  • [30] Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive impairment: Preliminary results
    Gattaz, WF
    Forlenza, OV
    Talib, LL
    Barbosa, NR
    Bottino, CMC
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S385 - S385
12345